Immunotherapy in particular, she said, could mean the difference between relapse and survival. Kiu said SCCS supported ...

There are two trials that I think are probably the most excited about. One of them is called the PEAK trial, and it was a ...

The upcoming fashion war has Forrester Creations making changes on The Bold and the Beautiful. Already one designer has been ...

Episode 3 features a backstage huddle before a show. Backup singer Jeslyn Gorman had to leave the tour after a cancer ...

The new Phase III study will test calderasib in a chemo-free regimen for G12C-mutated patients regardless of PD-L1 status.

The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

Hello, everyone, and thank you for joining us to review CSPi's Fiscal 2025 First Quarter Financial Results, as well as recent ...

SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...

Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...